Cleared Traditional

K770757 - PULSE/PHONOCARDIOGRAPHY CHANNEL, 144 (FDA 510(k) Clearance)

Class I Cardiovascular device.

K770757 · Honeywell, Inc. · Cardiovascular device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
May 1977
Decision
14d
Days
Class 1
Risk

K770757 is an FDA 510(k) clearance for the PULSE/PHONOCARDIOGRAPHY CHANNEL, 144. Classified as Phonocardiograph (product code DQC), Class I - General Controls.

Submitted by Honeywell, Inc. (Mchenry, US). The FDA issued a Cleared decision on May 9, 1977 after a review of 14 days - a notably fast clearance cycle.

This device falls under the Cardiovascular FDA review panel, regulated under 21 CFR 870.2390 - the FDA cardiovascular device oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Honeywell, Inc. devices

Submission Details

510(k) Number K770757 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received April 25, 1977
Decision Date May 09, 1977
Days to Decision 14 days
Submission Type Traditional
Review Panel Cardiovascular (CV)
Summary -
Third-party Review No - reviewed directly by FDA
Regulatory Context
Review time vs. panel average
111d faster than avg
Panel avg: 125d · This submission: 14d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code DQC Phonocardiograph
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 870.2390
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.